Skip to content

Clinical trials

Completed Phase 4 Parkinson Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinson Disease Phase: Phase 4 Status: Completed Clear all

105 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20033
20042
20055
200611
20078
20083
200911
20104
20118
201211
20133
20145
20152
20162
20174
20183
20195
20203
20215
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed105

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim7
Baylor College of Medicine4
Seoul National University Hospital4
Technische Universität Dresden4
Bial - Portela C S.A.3
GlaxoSmithKline3
Oregon Health and Science University3
Orion Corporation, Orion Pharma3
University of Pennsylvania3
Georgetown University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinson Disease105
Dementia4
Dyskinesias4
Cognitive Dysfunction3
Gait Disorders, Neurologic3
Gambling2
Lethargy2
Lewy Body Disease2
Multiple System Atrophy2
Parkinsonian Disorders2

Trials

Showing 1 to 25 of 105. Each trial links to its page on Pharma Observatory.

5 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.